SOS Q3 2018 Earnings Significant EPS Miss Amidst Operational Challenges TSM Q1 2026 Earnings Strong EPS Beat Signals Robust Demand Amid Cautious Market Response RDZN Q1 2026 Earnings Significant EPS Miss Raises Concerns GT Biopharma Q1 2026 Earnings Wider Loss and No Revenue as Pipeline Progress Remains Uncertain AVAH Q1 2026 Earnings EPS Surges Past Estimates Yet Stock Declines UFCS Q1 2026 Earnings EPS Surges Past Estimates by 37 as Stock Declines